Drugs
July 9, 2024 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Osteoporosis Drug Tested On Mice; Reduce Risk Of Stroke And Cognitive Impairment Through Diet; Walking Outside Shows Bone Health Benefits
This month’s bulletin begins with a study that could lead to a novel osteoporosis drug. We’ll examine what researchers have discovered and how it could affect the future of bone … Continue Reading →
May 14, 2024 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Greenery Benefits Bone; Proton Pump Inhibitors Increase Risk Of Stomach Cancer; Biotech Drug In The Works To Delay Or Prevent Menopause
This month’s new studies offer useful information on how to prevent osteoporosis and cancer, and possibly even delay or avoid menopause. We will cover all three topics, which involve the … Continue Reading →
May 7, 2024 by Vivian Goldschmidt, MA
Discover What Is Polypharmacy And If It Is A Threat To Your Bones And Wellbeing
As Big Pharma has risen to power and gained outsized influence within the Medical Establishment a troubling trend has emerged: polypharmacy. Polypharmacy is a situation in which a person is … Continue Reading →
April 30, 2024 by Vivian Goldschmidt, MA
Scientifically Proven: Knowledge Is Power When It Comes To Improving Your Health
The doctor-patient relationship plays an important role in health outcomes, yet its foundations have shifted significantly in recent decades. With the advent of the internet and digital communication, information about … Continue Reading →
April 16, 2024 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: New Tool Turns DXA Scans 3D; Study Associaties Prolia Doses With Reduced Risk Of Diabetes; Researchers Tout An Anti-Aging Elixir
This month’s bulletin covers new imaging technology, novel uses for old drugs, and a potential anti-aging elixir. First, we’ll look at a medical product out of Spain that uses technology … Continue Reading →
February 26, 2024 by Vivian Goldschmidt, MA
Alert! The FDA Issued Its Strictest Warning For Deadly Effects Of Osteoporosis Drug Prolia
The Food and Drug Administration (FDA) has added its strictest warning to Amgen’s osteoporosis drug Prolia (denosumab). The move comes after years of additional monitoring and testing of a known … Continue Reading →
December 21, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Bone Density Assessment Device Gets FDA Approval; Gene Manipulating Osteoporosis Drug In Development; Researchers Repurpose Malaria Drug For Osteoporosis
This month’s bulletin brings news of an onslaught of new medical devices and drugs targeting osteoporosis. First, we’ll discuss OsteoSight, a tool recently approved by the FDA designed to diagnose … Continue Reading →
November 20, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Skeletal Stem Cells Control Effects of Aging; Pain Reprocessing Therapy Offers Alternative To Painkillers; New Dangers Of Aspartame Uncovered
This month’s Save Our Bones Bulletin brings you breaking news from the realms of stem cell research, mental approaches to physical pain, and a shocking revelation regarding a widely used … Continue Reading →
October 9, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Newly Discovered Genetic Pathway For Bone Formation; 3D Scans May Predict Fracture Risk; Evolutionary Biology And Bone Regeneration
New research enriches our understanding of bone function and offers insights into maintaining their quality and strength. This bulletin dives into three new studies that point the way toward the … Continue Reading →
September 11, 2023 by Vivian Goldschmidt, MA
Save Our Bones Bulletin: Study Identifies Gene That Governs Bone Development; How Thyroid-Stimulating Hormone Impacts Osteoporosis Risk; Meta-Analysis Concludes That Walking Can Extend Your Life
This month we’ll explore studies on genes responsible for osteogenesis (bone development), the connection between thyroid function and osteoporosis, and the life-saving benefits of walking. First, we’ll analyze new research … Continue Reading →